Education
About Us
Working with TipRanks
Follow Us
Tatva Chintan Pharma Chem Limited (IN:TATVA)
:TATVA
TATVA Stock Chart & Stats
₹1388.35
-₹14.30(-1.60%)
At close: 4:00 PM EST
₹1388.35
-₹14.30(-1.60%)
Day’s Range― - ―
52-Week Range₹610.00 - ₹1,603.60
Previous CloseN/A
Volume13.99K
Average Volume (3M)12.52K
Market Cap
₹28.09B
Enterprise Value₹28.64B
Total Cash (Recent Filing)₹140.96M
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)85.7
Beta1.17
Next Earnings
May 01, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.07%
Share Statistics
EPS (TTM)4.50
Shares Outstanding23,392,056
10 Day Avg. Volume25,333
30 Day Avg. Volume12,516
Financial Highlights & Ratios
PEG Ratio-3.55
Price to Book (P/B)2.24
Price to Sales (P/S)4.33
P/FCF Ratio-32.09
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Diverse End MarketsServing multiple industrial end markets creates demand diversification and reduces reliance on any single cyclical sector. This structural exposure to pharmaceuticals, petrochemicals and energy storage supports stable long-term revenue potential as different end markets follow distinct cycles and secular trends.
Low Leverage Balance SheetA conservative capital structure with low debt and a robust equity base enhances financial flexibility, lowers refinancing risk, and enables funding of strategic capex or cyclical downturns without stressing liquidity. This underpins long-term resilience and growth optionality.
Operating Cash Supports EarningsPositive operational cash generation indicates core business converts profit into cash, supporting working capital and recurrent needs. Over time this fosters self-funded reinvestment and steadier operations, even if free cash flow is impacted by strategic capex in growth phases.
Bears Say
Negative Free Cash FlowPersistent negative free cash flow driven by heavy capex constrains liquidity and forces reliance on external funding or equity to finance investments. Over months this can pressure reserves, limit strategic optionality, and increase vulnerability if revenue or margins weaken.
Profitability Volatility & Revenue DeclineDeclining revenue and swingy net margins suggest inconsistent pricing power or rising input costs, reducing predictability of earnings. For a specialty chemicals maker, persistent margin volatility weakens reinvestment capacity and undermines long-term cash generation stability.
Falling Return On EquityA declining ROE indicates the company is generating lower profitability relative to shareholder capital, pointing to possible asset underutilization or lower product profitability. Over months this can signal structural issues with capital allocation and reduce long-term shareholder value creation.
Tatva Chintan Pharma Chem Limited News
TATVA FAQ
What was Tatva Chintan Pharma Chem Limited’s price range in the past 12 months?
Tatva Chintan Pharma Chem Limited lowest stock price was ₹610.00 and its highest was ₹1603.60 in the past 12 months.
What is Tatva Chintan Pharma Chem Limited’s market cap?
Tatva Chintan Pharma Chem Limited’s market cap is ₹28.09B.
When is Tatva Chintan Pharma Chem Limited’s upcoming earnings report date?
Tatva Chintan Pharma Chem Limited’s upcoming earnings report date is May 01, 2026 which is in 69 days.
How were Tatva Chintan Pharma Chem Limited’s earnings last quarter?
Tatva Chintan Pharma Chem Limited released its earnings results on Jan 21, 2026. The company reported ₹4.5 earnings per share for the quarter, the consensus estimate of ₹4.5 by ₹0.
Is Tatva Chintan Pharma Chem Limited overvalued?
According to Wall Street analysts Tatva Chintan Pharma Chem Limited’s price is currently Overvalued.
Does Tatva Chintan Pharma Chem Limited pay dividends?
Tatva Chintan Pharma Chem Limited pays a Annually dividend of ₹1 which represents an annual dividend yield of 0.07%. See more information on Tatva Chintan Pharma Chem Limited dividends here
What is Tatva Chintan Pharma Chem Limited’s EPS estimate?
Tatva Chintan Pharma Chem Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Tatva Chintan Pharma Chem Limited have?
Tatva Chintan Pharma Chem Limited has 23,392,056 shares outstanding.
What happened to Tatva Chintan Pharma Chem Limited’s price movement after its last earnings report?
Tatva Chintan Pharma Chem Limited reported an EPS of ₹4.5 in its last earnings report, expectations of ₹4.5. Following the earnings report the stock price went up 1.363%.
Which hedge fund is a major shareholder of Tatva Chintan Pharma Chem Limited?
Currently, no hedge funds are holding shares in IN:TATVA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited manufactures and sells specialty chemicals in India. The company offers a portfolio of structure directing agents for zeolites synthesis; phase transfer catalysts; electrolyte salts for super capacitor batteries; and pharmaceutical APIs, agrochemical products, and other specialty chemicals in the form of intermediates, disinfectants, catalysts, and solvents. It also provides quaternary compounds and quats, and bulk drugs, as well as trading of specialty chemicals. It serves various industries, including the automotive, petroleum, pharmaceutical, agro-chemicals, paints and coatings, dyes and pigments, personal care, and flavor and fragrances industries. The company also exports its products to approximately 25 countries. Tatva Chintan Pharma Chem Limited was incorporated in 1996 and is headquartered in Vadodara, India.
Technical Analysis
Fineotex Chemical Limited
―
IOL Chemicals & Pharmaceuticals Ltd.
―
Kiri Industries Limited
―
Punjab Chemicals & Crop Protection Ltd.
―
Yasho Industries Ltd.
―